MiR-513a-3p inhibits EMT mediated by HOXB7 and promotes sensitivity to cisplatin in ovarian cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer is a leading cause of cancer-related deaths in women.
• Understanding the molecular mechanisms regulating ovarian cancer progression and treatment resistance is crucial.
• MicroRNAs (miRNAs) are key regulators of gene expression implicated in various cancers.

Purpose of the Study:

• To elucidate the biological function and mechanism of action of miR-513a-3p in ovarian cancer.
• To investigate the role of miR-513a-3p in regulating cisplatin sensitivity and epithelial-mesenchymal transition (EMT).
• To determine the relationship between miR-513a-3p, HOXB7, and ovarian cancer progression.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and Western blotting to assess gene and protein expression.
• Immunohistochemistry to evaluate expression in patient tissues.
• Cell viability (MTT assay), migration, and invasion assays (Transwell, wound-healing).
• Dual-luciferase reporter assays to confirm target interactions.
• In vivo tumorigenesis experiments.

Main Results:

• HOXB7 expression was elevated, while miR-513a-3p was downregulated in ovarian cancer cells.
• Reduced miR-513a-3p expression promoted cell migration and invasion by regulating EMT.
• Lower miR-513a-3p levels increased cisplatin sensitivity and were associated with poor prognosis in relapsed patients.
• HOXB7 overexpression reversed the effects of miR-513a-3p, indicating it mediates these processes.
• miR-513a-3p regulates EMT mediated by HOXB7 and influences cisplatin resistance.

Conclusions:

• MiR-513a-3p acts as a tumor suppressor in ovarian cancer.
• It promotes cisplatin sensitivity and inhibits tumorigenesis by targeting HOXB7.
• Dysregulation of the miR-513a-3p/HOXB7 axis contributes to ovarian cancer progression and treatment resistance.